The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
eribulin mesylate · Solution
3 marketed package NDCs · 3 active manufacturers
Most dispensed: .5 mg/mL · Injection · #1 vial, single-dose/carton / 2 ml in 1 vial, single-dose · .5 mg/mL · Solution · #1 vial, single-dose/carton / 2 ml in 1 vial, single-dose
Same drug class
Other molecules FDA puts in Microtubule Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Eribulin mesylate in shortage right now?
- No. FDA does not currently list Eribulin mesylate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Eribulin mesylate?
- 24 companies have marketed Eribulin mesylate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.